Why Local Bacterial Strains Matter in the Fight Against AHPND/EMS

Acute Hepatopancreatic Necrosis Disease (AHPND), widely known as Early Mortality Syndrome (EMS), has become one of the most significant bacterial challenges facing shrimp production today. The disease is strongly associated with pathogenic strains of Vibrio parahaemolyticus — but calling the problem simply “Vibrio” can obscure an important biological reality: not every strain is the same.

Bacterial populations vary between countries, regions, farms, ponds, and even production cycles. Understanding those differences isn't academic — it's essential when working with precision technologies like bacteriophages.

The Same Species Can Behave Very Differently

Two bacteria can belong to the same species and still differ meaningfully in virulence, environmental adaptation, growth dynamics, and susceptibility to control strategies. The microbial environment around them is just as dynamic: temperature, salinity, organic matter, stocking density, water exchange, and biosecurity practices all influence which populations become dominant. As a result, the bacterial challenge on one farm is rarely identical to the challenge on another.

Regional Differences Matter

Aquaculture is shaped by local conditions. A farm on one stretch of coastline may face an entirely different bacterial population than a farm just a few hundred kilometers away — and even neighboring farms can develop distinct microbiological profiles, driven by differences in water sources, production systems, sediment conditions, disease history, and management practices. This creates a constantly shifting microbial ecosystem, where understanding the local picture can matter as much as identifying the pathogen species itself.

Why This Matters for Bacteriophages

Bacteriophages are naturally specialized infectors of bacteria — and unlike broad-spectrum approaches, that specificity is both their greatest strength and the reason characterization is essential. A phage that effectively infects one strain of Vibrio won't necessarily infect every strain circulating in shrimp production. That's why evaluating local bacterial isolates matters: it tells you whether the phages in a formulation are actually active against the strains present on a given farm, typically through bacterial susceptibility testing.

Building a Susceptibility Profile

At HEDROS, bacterial samples from production environments are analyzed to isolate strains of interest, which are then tested against a range of bacteriophages to identify which ones are effective. The resulting susceptibility profile informs how a phage cocktail is selected or developed — allowing the strategy to adapt to the microorganisms actually present, rather than treating every bacterial challenge as identical.

From Generic Disease Management to Precision Microbiology

Traditional disease management typically stops at the species level: is Vibrio parahaemolyticus present or not? Precision bacteriophage technology asks a more useful question — which strains are present, and which phages can infect them? That extra layer of information helps producers and technical teams make better-informed decisions, and opens the door to adapting formulations as bacterial populations evolve over time.

A Dynamic Problem Needs a Dynamic Approach

Microbial ecosystems don't sit still. A bacterial profile identified in one production cycle may look different in the next, as environmental conditions shift and new strains become dominant. That's why periodic bacterial monitoring is a critical part of long-term disease management — sampling, isolation, susceptibility testing, and technical follow-up form a

feedback loop that lets the strategy evolve alongside the farm.

Precision Starts Locally

AHPND is a global challenge, but the bacteria driving outbreaks live in local production environments. By combining bacterial diagnostics with phage susceptibility testing, HEDROS is working to move disease management toward a more precise model — one built not just on the name of the pathogen, but on the biological reality of the strains actually present in each system.

Because when bacteria are different, the solution should be able to tell the difference too.